Summary of Purpose
To assess the potential of warfarin to reduce systemic thromboembolism and its inherent risk of hemorrhage.Read More →
The following dates are available for this trial. Trial information last updated on 26 July 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Randomized, double-blind, placebo-controlled trial of 378 patients.